The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed

被引:189
作者
Riol-Blanco, L
Sánchez-Sánchez, N
Torres, A
Tejedor, A
Narumiya, S
Corbí, AL
Sánchez-Mateos, P
Rodríguez-Fernández, JL
机构
[1] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain
[2] Hosp Gen Gregorio Maranon, Expt Med Lab, Madrid, Spain
[3] Hosp Gen Gregorio Maranon, Serv Immunol, Madrid, Spain
[4] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan
关键词
D O I
10.4049/jimmunol.174.7.4070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CCR7 is necessary to direct dendritic cells (DCs) to secondary lymphoid nodes and to elicit an adaptative immune response. Despite its importance, little is known about the molecular mechanisms used by CCR7 to direct DCs to lymph nodes. In addition to chemotaxis, CCR7 regulates the migratory speed of DCs. We investigated the intracellular pathways that regulate CCR7-dependent chemotaxis and migratory speed. We found that CCR7 induced a G(i)-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs. CCR7 induced activation of PI3K/Akt; however, these enzymes did not regulate either chemotaxis or the speed of DCs. CCR7 also induced activation of the GTPase Rho, the tyrosine kinase Pyk2, and inactivation of cofilin. Pyk2 activation was independent of G(i) and Src and was dependent on Rho. Interference with Rho or Pyk2 inhibited cofilin inactivation and the migratory speed of DCs, but did not affect chemotaxis. Interference with Rho/Pyk2/cofilin inhibited DC migratory speed even in the absence of chemokines, suggesting that this module controls the speed of DCs and that CCR7, by activating its components, induces an increase in migratory speed. Therefore, CCR7 activates two independent signaling modules, one involving Gi and a hierarchy of MAPK family members and another involving Rho/Pyk2/cofilin, which control, respectively, chemotaxis and the migratory speed of DCs. The use of independent signaling modules to control chemotaxis and speed can contribute to regulate the chemotactic effects of CCR7.
引用
收藏
页码:4070 / 4080
页数:11
相关论文
共 75 条
[11]   Novel pathways of F-actin polymerization in the human neutrophil [J].
Chodniewicz, D ;
Zhelev, DV .
BLOOD, 2003, 102 (06) :2251-2258
[12]   Chemoattractant receptor-stimulated F-actin polymerization in the human neutrophil is signaled by 2 distinct pathways [J].
Chodniewicz, D ;
Zhelev, DV .
BLOOD, 2003, 101 (03) :1181-1184
[13]   Signaling pathways controlling cell polarity and chemotaxis [J].
Chung, CY ;
Funamoto, S ;
Firtel, RA .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (09) :557-566
[14]   Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines [J].
Cinamon, G ;
Shinder, V ;
Alon, R .
NATURE IMMUNOLOGY, 2001, 2 (06) :515-522
[15]   Chemokines trigger immediate β2 integrin affinity and mobility changes:: Differential regulation and roles in lymphocyte arrest under flow [J].
Constantin, G ;
Majeed, M ;
Giagulli, C ;
Piccio, L ;
Kim, JY ;
Butcher, EC ;
Laudanna, C .
IMMUNITY, 2000, 13 (06) :759-769
[16]   Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis [J].
Cronshaw, DG ;
Owen, C ;
Brown, Z ;
Ward, SG .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7761-7770
[17]   Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases [J].
Curnock, AP ;
Logan, MK ;
Ward, SG .
IMMUNOLOGY, 2002, 105 (02) :125-136
[18]  
del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609
[19]   Eukaryotic chemotaxis: Distinctions between directional sensing and polarization [J].
Devreotes, P ;
Janetopoulos, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) :20445-20448
[20]   Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites [J].
Dieu, MC ;
Vanbervliet, B ;
Vicari, A ;
Bridon, JM ;
Oldham, E ;
Aït-Yahia, S ;
Brière, F ;
Zlotnik, A ;
Lebecque, S ;
Caux, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :373-386